Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $1,200.00 price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments